The Vall d’Hebron Institute of Oncology (VHIO) Seeks a PhD Student to Join our Sarcoma Translational Research Group
Deadline for submission of applications: 1/12/2019
Number of vacancies: 1
The Vall d´Hebron Institute of Oncology´s (VHIO) Sarcoma Translational Research Group, headed by César Serrano MD PhD, is currently seeking to recruit a PhD Student. The successful candidate will form an integral part of the scientific team and will be directly involved in the identification and characterization of the molecular mechanisms involved in KIT oncogene – mediated addiction to a well-preserved transcriptomic program in gastrointestinal stromal tumors.
VHIO’s Sarcoma Translational Research Laboratory is a recently created research group with a highly motivating environment and connected interaction between the lab and the clinic. We focus on sarcoma translational research with an emphasis on the biological understanding of sarcomas towards drug development.
Requirements (degree, experience, additional training):
A highly motivated, team-oriented individual with previous experience in a biomedical research laboratory and highly skilled in molecular biology. The ideal candidate should be familiar with western blot and cancer cell culture, and also be prepared to work with human tissues. Previous experience working with high-throughput data will be favorably considered.
Candidates must submit a curriculum vitae and letter of intent via email addressed to César Serrano: email@example.com . Please also attach a letter of reference, if available.
Review of applications will commence immediately.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: http://www.vhio.net